Improved efficacy in the neoadjuvant treatment of locally advanced breast cancer (LABC)

被引：0
|
作者：
Smolanka, I. I.
Lygyrda, O. F.
Galakhin, K. A. [1 ]
Kudrjavetz, Y. J. [2 ]
机构：
[1] Inst Oncol, Dept Pathohistol, Kiev, Ukraine
[2] Pathol & Radiobiol NAS Ukraine, ER Kavetsky Inst Expt Oncol, Dept Bank Canc Cell Cultures, Kiev, Ukraine
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [41] Phase II open clinical trial to evaluate efficacy and safety of neoadjuvant trastuzumab in HER2-positive locally advanced breast cancer (LABC)
    Arce-Salinas, C. H.
    Lara, F. U.
    Leon, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Prognostic significance of axillary lymph node histology (pN) after neoadjuvant therapy for locally advanced breast cancer (LABC)
    Vitoc, C
    Rancea, A
    Rasinaru, A
    Todor, N
    Ghilezan, N
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 673 - 673
  • [43] Phase II study of neoadjuvant docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer (LABC)
    Perez-Manga, G.
    Mendez, M.
    Palomero, M. I.
    Quiben, R.
    Belon, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] A Phase 11 study of neoadjuvant chemotherapy (NC) with taxotere, adriamycin and cyclophosphamide (TAC) in locally advanced breast cancer (LABC)
    Lal, A.
    Alidina, A.
    Vaziri, I.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 122 - 122
  • [45] FUNCTIONAL IMAGING OF NEOADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY IN WOMEN WITH LOCALLY ADVANCED BREAST CANCER (LABC) USING DIFFUSE OPTICAL SPECTROSCOPY
    Soliman, H.
    Gunasekara, A.
    Rycroft, M.
    Zubovits, J.
    Dent, R.
    Spayne, J.
    Yaffe, M.
    Czarnota, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S14 - S14
  • [46] FDG PET can be useful to predict survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer (LABC)
    Rousseau, C.
    Campion, L.
    Pallardy, A.
    Campone, M.
    Testard, A.
    Ferrer, L.
    Bridji, B.
    Kraeber-Bodere, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S246 - S247
  • [47] Prediction of response of locally advanced breast cancer (LABC) to neoadjuvant anthracycline chemotherapy using 99mTc-sestamibi.
    Ang, P
    Balram, C
    Tan, PH
    Ang, EES
    Ong, SC
    Wong, ZW
    Lim, E
    Zhou, QY
    Ho, GH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 159S - 159S
  • [48] Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts)
    Rossi, Luigi
    Tomao, Federica
    Papa, Anselmo
    Zoratto, Federica
    Ricci, Fabio
    Spinelli, Gian Paolo
    Lo Russo, Giuseppe
    Basso, Enrico
    Caprio, Giuliana
    Barberi, Simona
    Verrico, Monica
    Giordani, Erika
    Zaccarelli, Eleonora
    Rinaldi, Giulia
    Stati, Valeria
    Pasciuti, Giulia
    Strudel, Martina
    Tomao, Silverio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Dynamic changes of miRNA and cancer related proteins (CRPs) expression during neoadjuvant chemotherapy (NAC) for locally advanced breast cancer (LABC).
    Al-Khanbashi, Maria
    Caramuta, Stefano
    Al-Ajmi, Adel
    Al-Hadabi, Ibrahim
    Kumar, Shiyam
    Dsouza, Philomena Charlotte
    Zahld, Khawaja Farhan
    Malik, Kamran Ahmed
    Muhammad, Furrukh
    Burney, Ikram A.
    Al Bahrani, Bassim J.
    Lui, Wang-onn
    Al-Moundhri, Mansour S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Why so late? Presentation delay in locally advanced breast cancer (LABC).
    Kerr-Cresswell, DM
    Fitzgerald, B
    Fergus, K
    Gould, J
    Lenis, M
    Clemons, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 56S - 56S
12345